111 Capital Buys 3,057 Shares of Cardinal Health, Inc. $CAH

111 Capital increased its stake in Cardinal Health, Inc. (NYSE:CAH) by 210.7% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,508 shares of the company’s stock after acquiring an additional 3,057 shares during the quarter. 111 Capital’s holdings in Cardinal Health were worth $926,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the business. Aventura Private Wealth LLC bought a new position in Cardinal Health during the fourth quarter valued at about $25,000. Jones Financial Companies Lllp lifted its holdings in Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the last quarter. JPL Wealth Management LLC purchased a new stake in Cardinal Health during the third quarter valued at about $31,000. Turning Point Benefit Group Inc. purchased a new stake in shares of Cardinal Health in the third quarter worth about $31,000. Finally, Cape Investment Advisory Inc. lifted its holdings in shares of Cardinal Health by 61.1% in the third quarter. Cape Investment Advisory Inc. now owns 211 shares of the company’s stock worth $33,000 after buying an additional 80 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

Cardinal Health Stock Up 2.0%

CAH stock opened at $205.79 on Friday. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $233.60. The stock has a market cap of $48.20 billion, a P/E ratio of 31.47, a PEG ratio of 1.10 and a beta of 0.52. The business’s 50-day moving average price is $202.53 and its 200-day moving average price is $208.57.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same period in the previous year, the firm earned $2.35 EPS. The business’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts expect that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a $0.5158 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a yield of 1.0%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is presently 31.19%.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the stock. William Blair assumed coverage on shares of Cardinal Health in a research report on Tuesday, April 28th. They issued an “outperform” rating on the stock. Leerink Partners reiterated an “outperform” rating and set a $275.00 price target on shares of Cardinal Health in a research report on Monday, March 9th. Wells Fargo & Company dropped their price target on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Mizuho raised their price target on Cardinal Health from $222.00 to $235.00 and gave the stock an “outperform” rating in a research note on Friday, February 6th. Finally, Barclays raised their price objective on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, February 24th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $241.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.